Michael E. Saladin

Dr. Michael E. Saladin

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Experimental and Clinical Psychopharmacology
Verified
Journal Article
Open access
AAAlicia M. Allen
Alicia M. Allen
AMAimee L. McRae-Clark
Aimee L. McRae-Clark
SCSamantha Carlson
Samantha Carlson
MSMichael E. Saladin
Michael E. Saladin
KGKevin M. Gray
Kevin M. Gray
SASharon S. Allen
Sharon S. Allen
Given the volume and importance of research focusing on menstrual phase, a review of the strategies being used to identify menstrual phase and recommendations that will promote methodological uniformity in the field is needed. We conducted a literature review via Ovid Medline and PsycINFO. Our goal was to review methods used to identify menstrual phase and subphases in biobehavioral research studies with women who had physiologically natural menstrual cycles. Therefore, we excluded articles that focused on any of the following: use of exogenous hormones, the postpartum period, menstrual-related problems (e.g., polycystic ovarian syndrome, endometriosis), and infertility/anovulation. We also excluded articles on either younger (45 years old) study samples. We initially identified a total of 1,809 articles. After our exclusionary criteria were applied, 146 articles remained, within which our review identified 6 different methods used to identify menstrual phase and subphases. The most common method used was self-report of onset of menses (145/146 articles) followed by urine luteinizing hormone testing (50/146 articles) and measurement of hormones (estradiol and/or progesterone) in blood samples (49/146 articles). Overall, we found a lack of consistency in the methodology used to determine menstrual phase and subphases. We provide several options to improve accuracy of phase identification, as well as to minimize costs and burden. Adoption of these recommendations will decrease misclassification within individual studies, facilitate cross-study comparisons, and enhance the reproducibility of results.

1 August 2008 in Addictive Behaviors
Verified
Journal Article
Closed access
CRCarla J. Rash
Carla J. Rash
SCScott F. Coffey
Scott F. Coffey
JBJoseph S. Baschnagel
Joseph S. Baschnagel
DDDavid J. Drobes
David J. Drobes
MSMichael E. Saladin
Michael E. Saladin

1 December 2003 in Addictive Behaviors
Verified
Journal Article
Closed access
MSMichael E. Saladin
Michael E. Saladin
DDDavid J Drobes
David J Drobes
SCScott F Coffey
Scott F Coffey
BDBonnie S Dansky
Bonnie S Dansky
KBKathleen T Brady
Kathleen T Brady
DKDean G Kilpatrick
Dean G Kilpatrick

11 April 2012 in The American Journal on Addictions
Verified
Journal Article
Closed access
PDF file
MSMichael E. Saladin
Michael E. Saladin
KGKevin M. Gray
Kevin M. Gray
MCMatthew J. Carpenter
Matthew J. Carpenter
SLSteven D. LaRowe
Steven D. LaRowe
SDStacia M. DeSantis
Stacia M. DeSantis
HUHimanshu P. Upadhyaya
Himanshu P. Upadhyaya

1 March 2017 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
LGLisa J. Germeroth
Lisa J. Germeroth
MCMatthew J. Carpenter
Matthew J. Carpenter
NBNathaniel L. Baker
Nathaniel L. Baker
BFBrett Froeliger
Brett Froeliger
SLSteven D. LaRowe
Steven D. LaRowe
MSMichael E. Saladin
Michael E. Saladin
The role of learning and memory processes in addiction has been well established in both theory and research.1-6 A fundamental source of this learning occurs when cues chronically paired with drug reward gradually acquire the capacity to elicit a range of conditioned responses, such as craving and physiological reactivity. In the case of nicotine-reinforced smoking addiction, individuals trying to quit smoking commonly report that cue-elicited craving plays a central role in smoking lapses.7-11 Smokers with increased vulnerability to cue-elicited craving and those who experience greater reactivity to cues are less likely to quit successfully.12-15 These findings, together with clinical studies demonstrating that first-line cessation medications have only modest effects on cue-elicited cigarette craving,16-19 suggest that there is a need to develop treatments aimed at reducing cue-induced craving and the associated relapse risk.

1 October 2006 in Addictive Behaviors
Verified
Journal Article
Closed access
MSMichael E. Saladin
Michael E. Saladin
KBKathleen T. Brady
Kathleen T. Brady
KGKen Graap
Ken Graap
BRBarbara Olasov Rothbaum
Barbara Olasov Rothbaum